Olsen D, Thomsen C, Andersen R, Madsen J, Jakobsen A, Brandslund I
Sci Rep. 2020; 10(1):20113.
PMID: 33208845
PMC: 7675974.
DOI: 10.1038/s41598-020-77109-8.
Halkjaer L, Troldborg A, Pedersen H, Jensen L, Hansen A, Hansen T
Front Immunol. 2020; 11:774.
PMID: 32431705
PMC: 7214740.
DOI: 10.3389/fimmu.2020.00774.
Zhang Y, Murugesan P, Huang K, Cai H
Nat Rev Cardiol. 2019; 17(3):170-194.
PMID: 31591535
PMC: 7880919.
DOI: 10.1038/s41569-019-0260-8.
Troldborg A, Jensen L, Deleuran B, Stengaard-Pedersen K, Thiel S, Jensenius J
Front Immunol. 2018; 9:581.
PMID: 29632534
PMC: 5879092.
DOI: 10.3389/fimmu.2018.00581.
Wehling C, Amon O, Bommer M, Hoppe B, Kentouche K, Schalk G
Clin Exp Immunol. 2016; 187(2):304-315.
PMID: 27784126
PMC: 5217898.
DOI: 10.1111/cei.12890.
Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
Mache C, Acham-Roschitz B, Fremeaux-Bacchi V, Kirschfink M, Zipfel P, Roedl S
Clin J Am Soc Nephrol. 2009; 4(8):1312-6.
PMID: 19556379
PMC: 2723971.
DOI: 10.2215/CJN.01090209.
Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family.
Grumach A, Leitao M, Arruk V, Kirschfink M, Condino-Neto A
Clin Exp Immunol. 2006; 143(2):297-304.
PMID: 16412054
PMC: 1809586.
DOI: 10.1111/j.1365-2249.2005.02988.x.
Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.
Messias-Reason I, Hayashi S, Nisihara R, Kirschfink M
Clin Exp Immunol. 2002; 127(2):310-5.
PMID: 11876755
PMC: 1906352.
DOI: 10.1046/j.1365-2249.2002.01772.x.
Reduced expression of C5a receptors on neutrophils from cord blood.
Nybo M, Sorensen O, Leslie R, Wang P
Arch Dis Child Fetal Neonatal Ed. 1998; 78(2):F129-32.
PMID: 9577284
PMC: 1720753.
DOI: 10.1136/fn.78.2.f129.
Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study.
Rother E, Schochat T, Peter H
Rheumatol Int. 1996; 15(6):231-7.
PMID: 8778951
DOI: 10.1007/BF00290376.
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.
Rother E, Lang B, Coldewey R, Hartung K, Peter H
Clin Rheumatol. 1993; 12(1):31-5.
PMID: 8467609
DOI: 10.1007/BF02231555.
Evaluation of complement activation in premature newborn infants with hyaline membrane disease.
Cat R, Rosario N, de Messias I, Resener T, Kirschfink M
Eur J Pediatr. 1993; 152(3):205-8.
PMID: 8444245
DOI: 10.1007/BF01956145.
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.
Bjorvatn B, Bjertnaes L, Fadnes H, Flaegstad T, Gutteberg T, Kristiansen B
Br Med J (Clin Res Ed). 1984; 288(6415):439-41.
PMID: 6419956
PMC: 1444687.
DOI: 10.1136/bmj.288.6415.439.
Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients.
Baatrup G, Petersen I, Kappelgaard E, Jepsen H, Svehag S
Clin Exp Immunol. 1984; 55(2):313-8.
PMID: 6230182
PMC: 1535805.
Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
Krauledat P, Krapf F, Manger B, Kalden J
Rheumatol Int. 1985; 5(3):97-101.
PMID: 3892637
DOI: 10.1007/BF00541327.
Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.
Seya T, Nagasawa S, Atkinson J
Clin Exp Immunol. 1985; 62(1):208-16.
PMID: 3851703
PMC: 1577402.
Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.
Geirsson A, Sturfelt G, Truedsson L
Ann Rheum Dis. 1987; 46(10):727-33.
PMID: 3689000
PMC: 1003378.
DOI: 10.1136/ard.46.10.727.
[Immune complexes in allergies: evidence of IgE-containing immune complexes in Churg-Strauss vasculitis].
Krapf F, Manger B, Kalden J
Klin Wochenschr. 1986; 64(12):563-9.
PMID: 3525977
DOI: 10.1007/BF01735320.
C3 degradation products (C3d) in normal pregnancy.
Jenkins J, Powell R
J Clin Pathol. 1987; 40(11):1362-3.
PMID: 3500968
PMC: 1141241.
DOI: 10.1136/jcp.40.11.1362.
Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell A, Elson C, Carter S, Dieppe P, Hutton C, Czudek R
Ann Rheum Dis. 1987; 46(1):55-64.
PMID: 3492971
PMC: 1002059.
DOI: 10.1136/ard.46.1.55.